Immunitybio Inc Working Capital to Net Assets Ratio
Immunitybio Inc working capital to net assets ratio. Immunitybio Inc (IBRX) has a Working Capital to Net Assets ratio of -535.8% as of September 2025. Working capital of $272.36 Million (current assets of $329.50 Million minus current liabilities of $57.13 Million) is measured against net assets of $-50.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Immunitybio Inc (2013–2024)
Working capital to net assets ratio of Immunitybio Inc from 2013 to 2024. This chart shows how Immunitybio Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at -535.8%, reflecting working capital of $272.36 Million against net assets of $-50.83 Million USD. Explore Immunitybio Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Immunitybio Inc Working Capital to Net Assets Ratio by Year (2013–2024)
Immunitybio Inc working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Immunitybio Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Immunitybio Inc total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -26.6% | $129.64 Million | $-488.13 Million | $184.59 Million | $54.94 Million | ▲ +13.7 pp |
| 2023 | -40.2% | $235.80 Million | $-585.94 Million | $294.08 Million | $58.28 Million | ▼ -120.3 pp |
| 2022 | 80.1% | $-360.28 Million | $-449.82 Million | $140.58 Million | $500.86 Million | ▲ +65.9 pp |
| 2021 | 14.2% | $-34.65 Million | $-243.91 Million | $334.35 Million | $369.00 Million | ▲ +51.0 pp |
| 2020 | -36.8% | $43.58 Million | $-118.49 Million | $111.71 Million | $68.13 Million | ▼ -73.4 pp |
| 2019 | 36.6% | $44.20 Million | $120.68 Million | $55.76 Million | $11.56 Million | ▼ -5.5 pp |
| 2018 | 42.1% | $61.51 Million | $146.01 Million | $88.77 Million | $27.26 Million | ▼ -8.9 pp |
| 2017 | 51.0% | $111.59 Million | $218.84 Million | $132.46 Million | $20.87 Million | ▼ -14.6 pp |
| 2016 | 65.6% | $192.59 Million | $293.42 Million | $205.15 Million | $12.55 Million | ▼ -16.2 pp |
| 2015 | 81.9% | $291.39 Million | $356.00 Million | $297.54 Million | $6.15 Million | ▼ -15.7 pp |
| 2014 | 97.5% | $56.97 Million | $58.42 Million | $59.37 Million | $2.40 Million | ▼ -41.4 pp |
| 2013 | 138.9% | $-4.02 Million | $-2.90 Million | $978.00K | $5.00 Million | — |